Description

Progynova (estradiola valerate) Coated Tablets 2 mg. №21

Ingredients:

Each tablet contains 2 mg of estradiol valerate as the active ingredient. Inactive ingredients include lactose, maize starch, povidone, talc, magnesium stearate, sucrose, macrogol, calcium carbonate, titanium dioxide (E171), and red iron oxide (E172).

Dosage:

The usual dosage is one tablet daily. It is important to follow your healthcare provider’s instructions regarding the dosage and duration of treatment.

Indications:

Progynova tablets are indicated for hormone replacement therapy in postmenopausal women. They are used to relieve symptoms of menopause and prevent osteoporosis.

Contraindications:

Do not use Progynova if you have a history of breast cancer, liver disease, or blood clots. It is important to discuss your medical history with your doctor before starting this medication.

Directions:

Take one tablet daily with or without food. Swallow the tablet whole with a glass of water. Do not crush or chew the tablet.

Scientific Evidence:

Studies have shown that estradiol valerate, the active ingredient in Progynova, effectively reduces menopausal symptoms and prevents bone loss in postmenopausal women. Research published in the Journal of Clinical Endocrinology & Metabolism demonstrated the efficacy of estradiol valerate in improving bone mineral density.

Additional Information:

It is important to attend regular follow-up appointments with your healthcare provider while taking Progynova. Inform your doctor of any side effects or concerns you may have during treatment.

Progynova works by supplementing the body with estradiol, a form of estrogen. Estradiol plays a key role in regulating the female reproductive system and is essential for maintaining bone health. By replacing the estrogen that the body no longer produces adequately after menopause, Progynova helps alleviate symptoms such as hot flashes, vaginal dryness, and mood swings.

Clinical trials have shown that Progynova is well-tolerated and effective in managing menopausal symptoms. A study published in Menopause: The Journal of The North American Menopause Society found that estradiol valerate significantly improved quality of life and reduced the frequency and severity of hot flashes in postmenopausal women.